Bioceres Crop Solutions Corp. (BIOX) Stock Competitors & Peer Comparison
See (BIOX) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Inputs Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BIOX | $0.46 | +0.17% | 28.8M | -0.43 | -$1.06 | N/A |
| CTA-PB | $67.35 | +0.15% | 59B | N/A | N/A | +0.93% |
| CTVA | $78.27 | +0.60% | 51.8B | 41.87 | $1.85 | +0.93% |
| CTA-PA | $53.10 | -1.01% | 35.6B | N/A | N/A | +0.93% |
| NTR | $68.25 | -0.81% | 33.2B | 14.05 | $4.91 | +3.17% |
| CF | $117.39 | +0.68% | 18B | 10.58 | $11.10 | +1.71% |
| ICL | $5.79 | -5.47% | 7.6B | 28.00 | $0.21 | +3.22% |
| MOS | $22.65 | -2.81% | 7.3B | 163.57 | $0.14 | +3.87% |
| SMG | $56.90 | -0.12% | 3.3B | 16.34 | $3.48 | +4.66% |
| FMC | $12.21 | -1.13% | 1.5B | -0.62 | -$19.62 | +10.75% |
Stock Comparison
BIOX vs CTA-PB Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, CTA-PB has a market cap of 59B. Regarding current trading prices, BIOX is priced at $0.46, while CTA-PB trades at $67.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas CTA-PB's P/E ratio is N/A. In terms of profitability, BIOX's ROE is -1.49%, compared to CTA-PB's ROE of +0.05%. Regarding short-term risk, BIOX is more volatile compared to CTA-PB. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check CTA-PB's competition here
BIOX vs CTVA Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, CTVA has a market cap of 51.8B. Regarding current trading prices, BIOX is priced at $0.46, while CTVA trades at $78.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas CTVA's P/E ratio is 41.87. In terms of profitability, BIOX's ROE is -1.49%, compared to CTVA's ROE of +0.05%. Regarding short-term risk, BIOX is more volatile compared to CTVA. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check CTVA's competition here
BIOX vs CTA-PA Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, CTA-PA has a market cap of 35.6B. Regarding current trading prices, BIOX is priced at $0.46, while CTA-PA trades at $53.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas CTA-PA's P/E ratio is N/A. In terms of profitability, BIOX's ROE is -1.49%, compared to CTA-PA's ROE of +0.05%. Regarding short-term risk, BIOX is more volatile compared to CTA-PA. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check CTA-PA's competition here
BIOX vs NTR Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, NTR has a market cap of 33.2B. Regarding current trading prices, BIOX is priced at $0.46, while NTR trades at $68.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas NTR's P/E ratio is 14.05. In terms of profitability, BIOX's ROE is -1.49%, compared to NTR's ROE of +0.09%. Regarding short-term risk, BIOX is more volatile compared to NTR. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check NTR's competition here
BIOX vs CF Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, CF has a market cap of 18B. Regarding current trading prices, BIOX is priced at $0.46, while CF trades at $117.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas CF's P/E ratio is 10.58. In terms of profitability, BIOX's ROE is -1.49%, compared to CF's ROE of +0.35%. Regarding short-term risk, BIOX is more volatile compared to CF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check CF's competition here
BIOX vs ICL Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, ICL has a market cap of 7.6B. Regarding current trading prices, BIOX is priced at $0.46, while ICL trades at $5.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas ICL's P/E ratio is 28.00. In terms of profitability, BIOX's ROE is -1.49%, compared to ICL's ROE of +0.04%. Regarding short-term risk, BIOX is more volatile compared to ICL. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check ICL's competition here
BIOX vs MOS Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, MOS has a market cap of 7.3B. Regarding current trading prices, BIOX is priced at $0.46, while MOS trades at $22.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas MOS's P/E ratio is 163.57. In terms of profitability, BIOX's ROE is -1.49%, compared to MOS's ROE of +0.06%. Regarding short-term risk, BIOX is more volatile compared to MOS. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check MOS's competition here
BIOX vs SMG Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, SMG has a market cap of 3.3B. Regarding current trading prices, BIOX is priced at $0.46, while SMG trades at $56.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas SMG's P/E ratio is 16.34. In terms of profitability, BIOX's ROE is -1.49%, compared to SMG's ROE of -0.34%. Regarding short-term risk, BIOX is more volatile compared to SMG. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check SMG's competition here
BIOX vs FMC Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, FMC has a market cap of 1.5B. Regarding current trading prices, BIOX is priced at $0.46, while FMC trades at $12.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas FMC's P/E ratio is -0.62. In terms of profitability, BIOX's ROE is -1.49%, compared to FMC's ROE of -0.83%. Regarding short-term risk, BIOX is more volatile compared to FMC. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check FMC's competition here
BIOX vs PURR Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, PURR has a market cap of 1.3B. Regarding current trading prices, BIOX is priced at $0.46, while PURR trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas PURR's P/E ratio is N/A. In terms of profitability, BIOX's ROE is -1.49%, compared to PURR's ROE of -0.23%. Regarding short-term risk, BIOX is more volatile compared to PURR. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check PURR's competition here
BIOX vs UAN Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, UAN has a market cap of 1.3B. Regarding current trading prices, BIOX is priced at $0.46, while UAN trades at $121.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas UAN's P/E ratio is 10.51. In terms of profitability, BIOX's ROE is -1.49%, compared to UAN's ROE of +0.40%. Regarding short-term risk, BIOX is more volatile compared to UAN. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check UAN's competition here
BIOX vs IPI Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, IPI has a market cap of 499.4M. Regarding current trading prices, BIOX is priced at $0.46, while IPI trades at $36.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas IPI's P/E ratio is 33.50. In terms of profitability, BIOX's ROE is -1.49%, compared to IPI's ROE of +0.03%. Regarding short-term risk, BIOX is more volatile compared to IPI. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check IPI's competition here
BIOX vs AVD Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, AVD has a market cap of 72.1M. Regarding current trading prices, BIOX is priced at $0.46, while AVD trades at $2.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas AVD's P/E ratio is -1.58. In terms of profitability, BIOX's ROE is -1.49%, compared to AVD's ROE of -0.22%. Regarding short-term risk, BIOX is less volatile compared to AVD. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check AVD's competition here
BIOX vs BHST Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, BHST has a market cap of 60.6M. Regarding current trading prices, BIOX is priced at $0.46, while BHST trades at $3.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas BHST's P/E ratio is -6.03. In terms of profitability, BIOX's ROE is -1.49%, compared to BHST's ROE of -0.88%. Regarding short-term risk, BIOX is less volatile compared to BHST. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check BHST's competition here
BIOX vs MULG Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, MULG has a market cap of 49.1M. Regarding current trading prices, BIOX is priced at $0.46, while MULG trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas MULG's P/E ratio is 18.21. In terms of profitability, BIOX's ROE is -1.49%, compared to MULG's ROE of +0.11%. Regarding short-term risk, BIOX is more volatile compared to MULG. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check MULG's competition here
BIOX vs BHIL-WT Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, BHIL-WT has a market cap of 49M. Regarding current trading prices, BIOX is priced at $0.46, while BHIL-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas BHIL-WT's P/E ratio is N/A. In terms of profitability, BIOX's ROE is -1.49%, compared to BHIL-WT's ROE of -0.82%. Regarding short-term risk, BIOX is less volatile compared to BHIL-WT. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check BHIL-WT's competition here
BIOX vs CGA Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, CGA has a market cap of 29.3M. Regarding current trading prices, BIOX is priced at $0.46, while CGA trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas CGA's P/E ratio is -0.98. In terms of profitability, BIOX's ROE is -1.49%, compared to CGA's ROE of +0.04%. Regarding short-term risk, BIOX is more volatile compared to CGA. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check CGA's competition here
BIOX vs LVRO Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, LVRO has a market cap of 15.1M. Regarding current trading prices, BIOX is priced at $0.46, while LVRO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas LVRO's P/E ratio is -0.03. In terms of profitability, BIOX's ROE is -1.49%, compared to LVRO's ROE of +11.90%. Regarding short-term risk, BIOX is more volatile compared to LVRO. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check LVRO's competition here
BIOX vs SEED Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, SEED has a market cap of 7.9M. Regarding current trading prices, BIOX is priced at $0.46, while SEED trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas SEED's P/E ratio is -1.48. In terms of profitability, BIOX's ROE is -1.49%, compared to SEED's ROE of +1.02%. Regarding short-term risk, BIOX is more volatile compared to SEED. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check SEED's competition here
BIOX vs AGRZ Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, AGRZ has a market cap of 6.5M. Regarding current trading prices, BIOX is priced at $0.46, while AGRZ trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas AGRZ's P/E ratio is 3.33. In terms of profitability, BIOX's ROE is -1.49%, compared to AGRZ's ROE of +0.37%. Regarding short-term risk, BIOX is less volatile compared to AGRZ. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check AGRZ's competition here
BIOX vs SVFD Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, SVFD has a market cap of 4.2M. Regarding current trading prices, BIOX is priced at $0.46, while SVFD trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas SVFD's P/E ratio is 0.07. In terms of profitability, BIOX's ROE is -1.49%, compared to SVFD's ROE of -367.30%. Regarding short-term risk, BIOX is less volatile compared to SVFD. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check SVFD's competition here
BIOX vs FMTO Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, FMTO has a market cap of 3.1M. Regarding current trading prices, BIOX is priced at $0.46, while FMTO trades at $3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas FMTO's P/E ratio is -0.00. In terms of profitability, BIOX's ROE is -1.49%, compared to FMTO's ROE of +75.78%. Regarding short-term risk, BIOX is less volatile compared to FMTO. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check FMTO's competition here
BIOX vs RKDA Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, RKDA has a market cap of 1.6M. Regarding current trading prices, BIOX is priced at $0.46, while RKDA trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas RKDA's P/E ratio is -0.18. In terms of profitability, BIOX's ROE is -1.49%, compared to RKDA's ROE of -2.19%. Regarding short-term risk, BIOX is more volatile compared to RKDA. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check RKDA's competition here
BIOX vs BHIL Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, BHIL has a market cap of 1.5M. Regarding current trading prices, BIOX is priced at $0.46, while BHIL trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas BHIL's P/E ratio is -0.01. In terms of profitability, BIOX's ROE is -1.49%, compared to BHIL's ROE of -0.82%. Regarding short-term risk, BIOX is more volatile compared to BHIL. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check BHIL's competition here
BIOX vs YTEN Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, YTEN has a market cap of 345.5K. Regarding current trading prices, BIOX is priced at $0.46, while YTEN trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas YTEN's P/E ratio is -0.02. In terms of profitability, BIOX's ROE is -1.49%, compared to YTEN's ROE of -15.08%. Regarding short-term risk, BIOX is less volatile compared to YTEN. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check YTEN's competition here
BIOX vs MBII Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, MBII has a market cap of 0. Regarding current trading prices, BIOX is priced at $0.46, while MBII trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas MBII's P/E ratio is -6.82. In terms of profitability, BIOX's ROE is -1.49%, compared to MBII's ROE of -0.54%. Regarding short-term risk, BIOX is less volatile compared to MBII. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check MBII's competition here
BIOX vs TNH Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.8M. In comparison, TNH has a market cap of 0. Regarding current trading prices, BIOX is priced at $0.46, while TNH trades at $83.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas TNH's P/E ratio is N/A. In terms of profitability, BIOX's ROE is -1.49%, compared to TNH's ROE of +0.43%. Regarding short-term risk, BIOX is more volatile compared to TNH. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check TNH's competition here